32 Dokumente gefunden

Reversible impairment of non-invasively assessed mitochondrial oxygen metabolism in the long-term course of patients with…

Abstract Background Sepsis is characterized by organ dysfunction due to infection, with increasing evidence of mitochondrial dysfunction assessed preclinically and invasively. Protoporphyrin IX-triplet state lifetime technique (PpIX-TSLT) permits non-invasive determination of cellular oxygen metabolism…
Berlin: SpringerOpen, 2025-11-14

Prognostic value of perioperative changes in serum primary metabolites in patients after major surgery under general anesthesia:…

Abstract Purpose Major surgery under general anesthesia substantially alters physiologic homeostasis. Nevertheless, the intricate effects on the metabolome are poorly studied. Metabolic fingerprints may allow the identification of patients at risk for unfavourable outcomes. Methods We conducted a secondary,…
Cham: Springer International Publishing, 2025-06

Qualitative comparison of decalcifiers for mouse bone cryosections for subsequent biophotonic analysis

Bone tissue, with its complex structure, often necessitates decalcification of the hard tissue for ex vivo morphological studies. The choice of a suitable decalcification method plays a crucial role in preserving desired features and ensuring compatibility with diverse imaging techniques. The search…
London: Macmillan Publishers Limited, part of Springer Nature, 2025-01-07

Mitochondrial oxygen metabolism as a potential predictor of weight loss after laparoscopic sleeve gastrectomy for class III…

The prevalence of obesity is increasing at an alarming rate in industrialized countries. Obesity is a systemic disease that causes not only macroscopic alterations, but also mitochondrial dysfunction. Laparoscopic sleeve gastrectomy (LSG) poses a potential therapeutic option for patients with severe…
Lausanne: Frontiers Media S.A., 2025-01-07

Reduction in Renal Heme Oxygenase-1 Is Associated with an Aggravation of Kidney Injury in Shiga Toxin-Induced Murine Hemolytic-Uremic…

aus: Toxins
Hemolytic-uremic syndrome (HUS) is a systemic complication of an infection with Shiga toxin (Stx)-producing enterohemorrhagic Escherichia coli , primarily leading to acute kidney injury (AKI) and microangiopathic hemolytic anemia. Although free heme has been found to aggravate renal damage in hemolytic…
Basel: MDPI, 2024-12-14

Effektivität und Nebenwirkungsprofil des langwirksamen Oxytocinagonisten Carbetocin im Vergleich zu Oxytocin

In einer retrospektiven monozentrischen Beobachtungsstudie wurde die therapeutische Sicherheit und Effektivität des langwirksamen Oxytocinagonisten Carbetocin mit einer Oxytocindauerinfusion nach nach Sectio caesarea verglichen. Zudem erfolgte die Analyse der Beeinflussung wichtiger Vitalparameter. In…

Spleen tyrosine kinase: a novel pharmacological target for sepsis-induced cardiac dysfunction and multi-organ failure

Sepsis is a systemic condition caused by a dysregulated host response to infection and often associated with excessive release of proinflammatory cytokines resulting in multi-organ failure (MOF), including cardiac dysfunction. Despite a number of effective supportive treatments (e.g. ventilation, dialysis),…
Lausanne: Frontiers Media S.A., 2024-11-04

Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic…

Introduction: Up to 40% of patients with typical hemolytic–uremic syndrome (HUS), characterized by microangiopathic hemolytic anemia and acute kidney injury (AKI), develop long-term consequences, most prominently chronic kidney disease (CKD). The transition from AKI to CKD, particularly in the context…
Lausanne: Frontiers Media S.A., 2024-10-10

The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic…

aus: Toxins
Hemolytic-uremic syndrome (HUS) is a rare complication of an infection with Shiga toxin (Stx)-producing Escherichia coli (STEC-HUS), characterized by severe acute kidney injury, thrombocytopenia and microangiopathic hemolytic anemia, and specific therapy is still lacking. Thrombomodulin (TM) is a multi-domain…
Basel: MDPI, 2024-09-20

Deletion of Sphingosine Kinase 2 Attenuates Acute Kidney Injury in Mice with Hemolytic-Uremic Syndrome

Typical hemolytic uremic syndrome (HUS) can occur as a severe systemic complication of infections with Shiga toxin (Stx)-producing Escherichia coli . Its pathology can be induced by Stx types, resulting in toxin-mediated damage to renal barriers, inflammation, and the development of acute kidney injury…
Basel: Molecular Diversity Preservation International, 2024-07-12

Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute…

Introduction: Outcome-prediction in patients with sepsis is challenging and currently relies on the serial measurement of many parameters. Standard diagnostic tools, such as serum creatinine (SCr), lack sensitivity and specificity for acute kidney injury (AKI). Circulating cell-free DNA (cfDNA), which…
Lausanne: Frontiers Media S.A., 2024-05-13

Dually Modified Cellulose as a Non-Viral Vector for the Delivery and Uptake of HDAC3 siRNA

RNA interference can be applied to different target genes for treating a variety of diseases, but an appropriate delivery system is necessary to ensure the transport of intact siRNAs to the site of action. In this study, cellulose was dually modified to create a non-viral vector for HDAC3 short interfering…
Basel: MDPI, 2023-11-23

Insights into S. aureus -Induced Bone Deformation in a Mouse Model of Chronic Osteomyelitis Using Fluorescence and Raman…

Osteomyelitis is an infection of the bone that is often difficult to treat and causes a significant healthcare burden. Staphylococcus aureus is the most common pathogen causing osteomyelitis. Osteomyelitis mouse models have been established to gain further insights into the pathogenesis and host response.…
Basel: Molecular Diversity Preservation International, 2023-06-05

Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy

Sepsis-associated encephalopathy (SAE) is a severe and frequent complication of sepsis causing delirium, coma, and long-term cognitive dysfunction. We identified microglia and C1q complement activation in hippocampal autopsy tissue of patients with sepsis and increased C1q-mediated synaptic pruning in…
Washington, DC: Assoc., 2023-05-26

Bruton’s tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic…

Hemolytic-uremic syndrome (HUS) can occur as a complication of an infection with Shiga-toxin (Stx)-producing Escherichia coli . Patients typically present with acute kidney injury, microangiopathic hemolytic anemia and thrombocytopenia. There is evidence that Stx-induced renal damage propagates a pro-inflammatory…
Lausanne: Frontiers Media S.A., 2023-02-23

Der Einfluss von Shiga Toxin auf Biosynthese und Transport von Cholesterin im experimentellen hämolytisch-urämischen Syndrom…

Das hämolytisch-urämische Syndrom (HUS) ist eine schwere Komplikation einer Infektion mit enterohämorrhagischen Escherichia coli (EHEC), für die es keine kausale Therapie gibt. In zwei experimentellen Toxämie-Modelle der Maus (Dennhardt et al. 2018) konnten nach intravenöser (i.v.) Applikation von Shiga-Toxin…

Unravelling the therapeutic potential of erythropoietin signaling in hemolytic-uremic syndrome in mice : a preclinical work-up…

Typical hemolytic-uremic syndrome (HUS) occurs as a severe complication of an infection with enterohemorrhagic Escherichia coli (EHEC) and is one of the major causes of acute and chronic renal failure in children. HUS is clinically characterized by a symptom triad comprised of acute kidney injury (AKI),…

Targeting the innate repair receptor axis via erythropoietin or pyroglutamate helix B surface peptide attenuates hemolytic-uremic…

Hemolytic-uremic syndrome (HUS) can occur as a systemic complication of infections with Shiga toxin (Stx)-producing Escherichia coli and is characterized by microangiopathic hemolytic anemia and acute kidney injury. Hitherto, therapy has been limited to organ-supportive strategies. Erythropoietin (EPO)…
Lausanne: Frontiers Media, 2022-09-23